Monopar Therapeutics Inc. Public Float
Monopar Therapeutics Inc. (MNPR) had Public Float of $155.53 million as of 2025-06-30, per its 10-K/A filed 2026-04-01.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-04-01
- 2025-06-30: Entity Public Float $155.53M.
- 2024-06-30: Entity Public Float $6.41M.
- 2023-06-30: Entity Public Float $4.61M.
- 2022-06-30: Entity Public Float $10.00M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $155.53M 10-K/A · filed 2026-04-01 |
| 2024-06-30 | $6.41M 10-K · filed 2025-03-31 |
| 2023-06-30 | $4.61M 10-K · filed 2024-03-28 |
| 2022-06-30 | $10.00M 10-K · filed 2023-03-23 |
| 2021-06-30 | $25.24M 10-K · filed 2022-03-24 |
| 2020-06-30 | $17.44M 10-K · filed 2021-03-25 |
| 2019-06-30 | $0.00 10-K · filed 2020-03-27 |
| 2018-06-30 | $0.00 10-K · filed 2019-02-26 |
| 2017-06-30 | $0.00 10-K · filed 2018-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |